Omada Health beats on revenue in first earnings report since IPO
Aug 7, 2025, 4:57 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Despite net losses, revenue growth and improved membership indicate strong market positioning, akin to similar companies that experienced stock price surges after positive growth reports, such as Teladoc Health after their quarterly earnings releases.
AI summary
What happened, with direct paths to the underlying reporting
Omada reported Q2 revenue of $61 million, exceeding estimates. Net loss decreased to $5.31 million, showing improved financial health. The company expects 2023 revenue to reach $235-$241 million, higher than forecasts. Total membership grew 52% year-over-year, reaching 752,000 members. CEO highlights success in AI implementation and chronic care solutions.
Omada reported Q2 revenue of $61 million, exceeding estimates.
Net loss decreased to $5.31 million, showing improved financial health.
The company expects 2023 revenue to reach $235-$241 million, higher than forecasts.
Total membership grew 52% year-over-year, reaching 752,000 members.
CEO highlights success in AI implementation and chronic care solutions.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Omada Health will prescribe GLP-1 drugs starting in 2026. TrumpRx announces significant discounts for GLP-1 medications. Omada aims to ease complexities for primary care providers…
Omada Health to prescribe GLP-1s, enhancing its weight management program. Membership exceeds 100,000, indicating strong growth potential. Market for GLP-1s could reach $100 billi…
Omada Health raised $150 million in its IPO. The stock debuted on Nasdaq under the symbol 'OMDA'. OMDA's valuation exceeds $1 billion post-IPO. This reflects increasing investor i…
Omada Health's IPO closed at $23, up 21% from $19. The IPO valued Omada over $1 billion, matching its previous VC valuation. CEO Sean Duffy sees IPO as validation of market need f…